Skip to main content
Article
A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia
BMJ Open
  • Alice Fabbri, University of Sydney
  • Quinn Grundy, University of Sydney
  • Barbara Mintzes, University of Sydney
  • Swestika Swandari, University of Sydney
  • Ray Moynihan, Bond University
  • Emily Walkom, University of Sydney
  • Lisa A Bero, University of Sydney
Date of this Version
6-30-2017
Document Type
Journal Article
Publication Details

Published version

Fabbri, A., Grundy, Q., Mintzes, B., Swandari, S., Moynihan, R., Walkom, E., & Bero, L. A. (2017). A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia. BMJ Open, 7(6).

Access the journal

Copyright © Article author(s), 2017

Distribution License
Creative Commons Attribution-Noncommercial 4.0
Abstract

OBJECTIVES:

To analyse patterns and characteristics of pharmaceutical industry sponsorship of events for Australian health professionals and to understand the implications of recent changes in transparency provisions that no longer require reporting of payments for food and beverages.

DESIGN:

Cross-sectional analysis.

PARTICIPANTS AND SETTING:

301 publicly available company transparency reports downloaded from the website of Medicines Australia, the pharmaceutical industry trade association, covering the period from October 2011 to September 2015.

RESULTS:

Forty-two companies sponsored 116 845 events for health professionals, on average 608 per week with 30 attendees per event. Events typically included a broad range of health professionals: 82.0% included medical doctors, including specialists and primary care doctors, and 38.3% trainees. Oncology, surgery and endocrinology were the most frequent clinical areas of focus. Most events (64.2%) were held in a clinical setting. The median cost per event was $A263 (IQR $A153-1195) and over 90% included food and beverages.

CONCLUSIONS:

Over this 4-year period, industry-sponsored events were widespread and pharmaceutical companies maintained a high frequency of contact with health professionals. Most events were held in clinical settings, suggesting a pervasive commercial presence in everyday clinical practice. Food and beverages, known to be associated with changes to prescribing practice, were almost always provided. New Australian transparency provisions explicitly exclude meals from the reporting requirements; thus, a large proportion of potentially influential payments from pharmaceutical companies to health professionals will disappear from public view.

Citation Information
Alice Fabbri, Quinn Grundy, Barbara Mintzes, Swestika Swandari, et al.. "A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia" BMJ Open Vol. 7 Iss. 6 (2017) p. 016701 ISSN: 2044-6055
Available at: http://works.bepress.com/ray_moynihan/22/